|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.03% | +6.41% | +0.03% | +9.24% | +8.59% | +11.83% | +38.36% | -15.80% | +216.02% | 49.06B | |
| -0.69% | -0.58% | +2.81% | +38.93% | +19.13% | +48.58% | +36.48% | +10.54% | +239.64% | 44.6B | |
| +1.67% | +5.90% | -0.64% | +6.04% | +156.43% | +343.34% | +637.89% | +637.89% | - | 43.24B | |
| -0.41% | -0.28% | +2.08% | +26.58% | +20.82% | +10.28% | +104.07% | +1.52% | +1,135.04% | 41.73B | |
| +0.34% | -1.38% | -6.19% | +7.84% | +3.78% | +5.53% | +47.36% | -17.42% | +134.21% | 29.93B | |
| +0.78% | -1.43% | +4.58% | +16.17% | +10.60% | +24.05% | +156.56% | +231.02% | +2,044.29% | 17.19B | |
| -2.56% | +6.65% | +30.56% | +41.18% | +39.41% | +4.77% | - | - | - | 15.35B | |
| -3.20% | -2.38% | +5.31% | +10.50% | +22.12% | +25.00% | +43.67% | -31.13% | +88.82% | 15.54B | |
| -0.77% | -4.00% | -13.30% | -13.52% | - | - | - | - | - | 15.11B | |
| +0.52% | +3.67% | +2.55% | +31.04% | +48.18% | +101.09% | +50.82% | -30.14% | +258.11% | 14.06B | |
| -3.00% | +1.88% | +3.19% | -1.58% | -6.57% | +4.17% | -30.86% | -36.39% | +123.67% | 13.55B | |
| -1.43% | 0.00% | +18.22% | +251.15% | +233.33% | +164.03% | +98.09% | +28.57% | +1,676.82% | 12.21B | |
| -0.19% | -0.20% | +0.13% | +2.12% | +23.12% | +38.63% | +6.37% | -40.96% | +167.52% | 11.37B | |
| -0.35% | -4.76% | -1.83% | +63.30% | +51.18% | +28.03% | +38.20% | -55.82% | - | 10.86B | |
| -1.28% | -9.22% | -6.74% | +1.35% | +42.40% | +89.40% | +697.12% | +89.56% | - | 9.31B | |
| -1.10% | -3.45% | -5.20% | +15.15% | +60.36% | +115.01% | +739.69% | +697.15% | +574.66% | 9.22B | |
| -1.38% | +1.95% | +2.89% | +11.94% | -5.91% | -3.70% | -1.47% | -22.64% | +43.97% | 9.31B | |
| 0.00% | -7.50% | -13.91% | -0.77% | -30.36% | +19.27% | +462.00% | +191.65% | +1,034.64% | 8.31B | |
| -1.54% | -6.86% | -20.06% | -20.12% | -4.99% | +434.60% | +991.72% | +0.04% | - | 7.98B | |
| Average | -0.81% | +0.27% | +0.24% | +26.13% | +38.42% | +81.33% | +242.12% | +96.33% | +595.19% | 18.9B | |
| Weighted average by Cap. | -0.45% | +1.44% | +0.94% | +23.69% | +41.37% | +79.30% | +193.54% | +107.38% | +547.60% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
